Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

United Therapeutics (UTHR) Cost of Revenue (2016 - 2026)

United Therapeutics' Cost of Revenue history spans 17 years, with the latest figure at $103.4 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 36.23% to $103.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $384.4 million, a 24.12% increase, with the full-year FY2025 number at $384.4 million, up 24.12% from a year prior.
  • Cost of Revenue hit $103.4 million in Q4 2025 for United Therapeutics, up from $100.9 million in the prior quarter.
  • Over the last five years, Cost of Revenue for UTHR hit a ceiling of $103.4 million in Q4 2025 and a floor of $23.0 million in Q1 2021.
  • Historically, Cost of Revenue has averaged $61.3 million across 5 years, with a median of $67.1 million in 2023.
  • Biggest five-year swings in Cost of Revenue: decreased 20.16% in 2022 and later surged 115.82% in 2023.
  • Tracing UTHR's Cost of Revenue over 5 years: stood at $34.6 million in 2021, then skyrocketed by 69.94% to $58.8 million in 2022, then grew by 20.75% to $71.0 million in 2023, then rose by 6.9% to $75.9 million in 2024, then soared by 36.23% to $103.4 million in 2025.
  • Business Quant data shows Cost of Revenue for UTHR at $103.4 million in Q4 2025, $100.9 million in Q3 2025, and $87.6 million in Q2 2025.